Novartis Secures European Approval For Biosimilar Cancer Treatment Rixathon

The Chinese TDI market decreased in June 2017. The TDI price was weak at the beginning of June. The prices for TDI produced by BASF continued to go down, and prices for Chinese-made TDI followed the downtrend. Since the domestic factories held a meeting and units in Juli Chemistry and Fujian Southeast Electrochemical started to take overhaul, the Chinese TDI price increased in a short time. However, the downstream market was weak and the price dropped.
Though the traders’ inventory was at a low level, they had to cut prices to promote sales amid the bearish sentiments.The downstream demand was flat influenced by the by the ‘buy-high’ mentality. The demand was on a need-to basis.
At the end of June, the downstream players were bearish about the coming TDI market. Most buyers held wait-and-see attitude and waited the price to drop. Up to June 30, the Chinese mainstream negotiation price was RMB 22,600/mt, which fell RMB 2,600/mt or 10.32% M-O-M. The Shanghai mainstream negotiation price was RMB 22,900/mt, which fell RMB 2,900/mt or 11.24% M-O-M. At present, the bearish atmosphere is strong. In the future, it is predicted that the Chinese TDI market will continue to slip because of lack of messages.
2026-09-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
European dimethyl carbonate prices stabilized in August amid a rebound in market activity, and may rise in September
-
Novartis Reports Strong Q3 2023 Financial Results, Driven by Key Blockbuster Drugs
-
European Coatings Show 2023
-
Novartis sells 5 products
-
The multinational pharmaceutical company plans to sell its business
-
European oil and gas industry grapples with gas crisis
-
Novartis Sandoz Launches First Esbriet Generic in US
-
Novartis Suspends Production of Two Radioligand Drugs Due to Potential Quality Issues
-
The Most Expensive Drug in The World! Novartis' SMA Gene Therapy Zolgensma Strengthens Its Performance And Is About to Land in China
-
Novartis Global Restructuring To Cut Thousands of Jobs
Recommend Reading
-
Samsung Biologics Launches Formal Bid for PolyPeptide, Reshaping the Global Peptide API CDMO Map
-
Supply Chain Resilience Reshapes Chemical Competition: What Lies Behind BASF’s Stable Outlook
-
Geopolitical Conflict Drives Up Chemical Costs: The Industry Signal Behind DuPont’s Upgraded Outlook
-
Korea’s Petrochemical Pivot: Industry Embraces Historic Restructuring to Slash Overcapacity
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
MTBE Market Prices Deeply Decline
-
Formic Acid Market Operating Steadily
-
Negative Factors Dominate; Adipic Acid Prices Weakly Decline in June
-
Geopolitical Conflicts Reignite, Why Lithium Carbonate Has Not Shown the Same Frenzy as 4 Years Ago in China
-
Ethylene Glycol Prices Drop in June; Market May Stop Falling and Stabilize